Τόμος 18 (2000) – Τεύχος 3 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 18 (2000) – Issue 3 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Άννα  Δελτσίδου¹, Κατερίνα Λυκερίδου², Σταύρος Πλέσσας³

¹Γενικό Περιφερειακό Νοσοκομείο Αλεξάνδρα, Αθήνα, Ελλάς ²Τεχνολογικό Εκπαιδευτικό Ίδρυμα , Τμήμα Μαιευτικής, Αθήνα ,Ελλάς ³ Εθνικό Καποδιστριακό Πανεπιστήμιο Αθηνών, Τμήμα Νοσηλευτικής, Αθήνα, Ελλάς

Anna Deltsidou¹, Katerina Lykeridou², Stavros Τ. Plessas³

¹Alexandra General Hospital, Athens, Greece ²Technological Educational Institution of Ath­ens, Greece ³ Department of Nursing, University of Athens, Greece

2. Niebyl J.: Teratology and Drugs in Pregnancy and Lac­tation. In: Danforth’ s, Obstetrics and Gynecology. 6^th ed. Pp. 273 J.B. Lippincott Company, Philadelphia, 1990

3. Κίτσιου-Τζέλη Σ.: Τερατογόνοι Παράγοντες και Συγγενείς Ανωμαλίες. σελ. 135-160, Αθήνα, 1992

4. Herbst A.L.: Diethylstilboestrol exposure-1984. N. Engl. J. Med. 311: 1433-1434 (1984)

5. Lee E.W., D’ Alonzo G.E.: Cigarette smoking, nicotine addiction and pharmacologic treatment. Arch. Intern. Med. 153: 34-48 (1993)

6. Behnke M., Eyler F.D.: The consequences of prenatal substance use for the developing fetus, newborn, and young child. Intern. J. Addict. 28: 1341-1391 (1993)

7. Youngstrom N.: Fetal alcohol syndrome carries severe deficits. APA Monitor. 23(4): 32 (1992)

8. Streissguth A.P., Aase J.M., Clarren S.K., et al.: Fetal alcohol syndrome in adolescents and adults. JAMA 265: 1961-1967 (1991)

9. Wagner C., Katikaneni L., Cox T., Ryan R.: The impact of prenatal drug exposure on the neonate. Obstet. Gynecol. Clin. North Am. 25: 169-194 (1998)

10. Knuppel R.: Maternal- Placental- Fetal Unit; Fetal & Early Neonatal Physiology. In: (DeCherney A, Pernoll M, eds) Obstetrics & Gynecologic Diagnosis & Treatment. 8th ed. Pp.155-163, Appleton & Lange, Connecticut, 1994

11. Briggs G.G., Bodendorfer T., Freeman R.K., et al.: Drugs in Pregnancy and Lactation. Williams & Wilkins, Baltimore, 1993

12. Little B.B., Van Beveren T.T.: Placental transfer of selected substances of abuse. Semin. Perinatol. 20: 147-153 (1996).

13. Little B.B., Roe D.A., Stettler R.W., et al.: A new pla­cental enzyme in the metabolism of cocaine: An in vitro animal model. Am. J. Obstet. Gynecol. 172: 1441-1445 (1995)

14. Roe D., Little B.B., Bawdon R.E., et al.: Metabolism of cocaine by human placenta: Implications for fetal expo­sure. Am. J. Obstet. Gynecol. 116: 713-718 (1990)

15. Janiaux E., Gulbis B.: In vivo investigation of placental transfer early in human pregnancy. Eur. J. Obstet. Gyne­col. Reprod. Biol. 92: 45-49 (2000)

16. Smith D.W.: Recognizable Patterns of Human Malfor­mations. 3th ed. W.B. Saunders Co., Philadelphia, 1980

17. Ward R.M.: Drug therapy of the fetus. J. Clin. Pharmacol. 33: 780-789 (1993)

18. West J.R., Chen W.J., Pantazis N.J.: Fetal alcohol syndrome: The vulnerability of the developing brain and possible mechanisms. Metab. Brain Dis. 9: 291-322 (1994)

19. Lester B.M., LaGasse L., Freier K., et al.: Studies of cocaine-exposed human infants. NIDA Res. Monogr. 164: 175-210 (1996)

20. Hendrickx A.G., Peterson P., Hartmann D., Hummler H.: Vitamin A teratogenicity and risk assessment in the macaque retinoid model. Reprod. Toxicol. 14: 311-23 (2000)

21. Plessinger M.A., Woods J.R.: Maternal, placental, and fetal pathophysiology of cocaine exposure during preg­nancy. Clin. Obstet. Gynecol. 36: 267-278 (1993)

22. Anderson D.F., Phernetton T.M., Rankin J.H.: Predic­tion of fetal drug concentrations. Am. J. Obstet. Gynecol. 137: 735-738 (1980)

23. Garland M.: Pharmacology of Drug Transfer Across the Placenta. Obstet. Gynecol. Clin. North Am. 25: 21-40 (1998)

24. Sastry B.V.: Techniques to study human placental transport. Adv. Drug Deliv. Rev. 38(1): 17-39 (1999)

25. Krauer B., Krauer F., Hytten F.E.: Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol. Ther. 10: 301-328 (1980)

26. Reynolds F., Knott C.: Pharmacokinetics in pregnancy and placental drug transfer. Oxf. Rev. Reprod. Biol. 11: 389-449 (1989)

27. Schneider H., Sodha R.J., Progler M., et al.: Perme­ability of the human placenta for hydrophilic substances studied in the isolated dually in vitro perfused lobe. Contrib. Gynecol. Obstet. 13: 98-103 (1985)

28. de Swiet M., et al.: Embryology. In: (de Swiet M., Chamberlain G., eds) Basic Science in Obstetrics and Gynecology. 2^nd ed. Pp. 27-52, Churchill Livingstone, Edimburg, 1992

29. Hill M.D., Abramson F.P.: The significance of plasma protein binding on the fetal/ maternal distribution of drugs at steady-state. Clin. Pharmacokinet. 14: 156-170 (1988)

30. Perruca E., Crema A.: Plasma protein binding of drugs in pregnancy. Clin. Pharmacokin. 7: 336-352 (1982)

31. Juchau M.R., Dyer D.C.: Pharmacology of the pla­centa. Pediatr. Clin. North Am. 19: 65-79 (1972)

32. Dutton G.J., Leakey J.E.A.: The perinatal development of drug-metabolizing enzymes: What factors trigger their onset? Prog. Drug Res. 25: 189-273 (1981)

33. Dancis J., Lee J.D., Mendoza S., et al: Transfer and metabolism of dideoxyinosine by the perfused human placenta. J. Acqui. Immune Defic. Syndr. Hum. Retrovirol. 6: 2-6 (1993)

34. Szeto H.H., Umans J.G., McFarland J.: A comparison of morphine and methadone disposition in the maternal-fetal unit. Am. J. Obstet. Gynecol. 143: 700-706 (1982)

35. Seeds A.E.: Basic concepts of maternal-fetal amniotic fluid exchange: Their relevance to fetal therapeutics. Pedi­atr. Clin. North Am. 28: 231-240 (1981)

36. Garland M., Daniel S.S., Myers M.M., et al: Placental transfer and fetal metabolism of zidovudine in the baboon. J. Soc. Gynecol. Invest. 3: 276A (1996)

37. Yoo S.D., Rurak D.W., Taylor S.M., et al: Transpla­cental and nonplacental clearances of diphenhydramine in the chronically instrumented pregnant sheep. J. Pharm. Sci. 82: 145-149 (1993)

38. Deltsidou A., Lykeridou K., Plessas S.: Congenital anomalies and aetiology. Epitheor. Klin. Farmakol. Farma­kokinet.  (International Edition) 14: 111-115 (2000)